Posted by Michael Wonder on 23 Aug 2023
Dupilumab for the treatment of patients with prurigo nodularis
23 August 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use of dupilumab in the NHS in England.
For the time being, dupilumab is not recommended for the treatment of adults with moderate to severe prurigo nodularis when systemic treatment is suitable.
